Newleos Expands Leadership to Advance Neuropsychiatric Programs
April 8, 2025
Seasoned clinical and medical experts join to propel potential first- and best-in-class programs in anxiety, substance use disorders and cognitive impairment Newleos Therapeutics, Inc., a